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Abstract
Background:  This paper attempts to clarify the usefulness of various simple pre-operative
measures in estimating the potential for a visually successful capsulotomy.
Methods: 24 patients attending for capsulotomy had pre-operative measures of glare with BAT
tester, visibility of posterior pole and grading of posterior capsular pearls and fibrosis seen at slit
lamp. Visual function was measured before and after standardised capsulotomy. Correlations of the
various preoperative measures with eventual visual function improvements were calculated.
Results:  Pearls at slit lamp and poor posterior pole visualisation were all correlated with
improvements in visual acuity and contrast sensitivity after capsulotomy. Amount of fibrosis visible
at slit lamp and glare assessment were not correlated with vision improvements after laser.
Conclusion: Of the various measures that are taken prior to Nd : YAG capsulotomy, some
correlate with eventual visual improvement but for others no clinical utility was found.
Practitioners should note these findings as they are especially of use in more questionable or high-
risk cases to help determine whether referral for PCO treatment by Nd: YAG capsulotomy is likely
to benefit the patient.
Background
Posterior capsular opacification (PCO) remains one of the
most common post operative morbidities in modern day
cataract surgery [1,2] and Nd:YAG posterior capsulotomy
is one of the most commonly performed surgical
procedures.
However, the Nd: YAG capsulotomy procedure has been
associated with complications such as damage to intraoc-
ular lenses [3], post operative intraocular pressure
increases [4], cystoid macular oedema [4], disruption of
the anterior vitreous face [5] and increased incidence of
retinal detachment [6].
Until recently Nd:YAG laser treatments have cost the U.S
healthcare system up to $250 million annually [7]. Apart
from exposing a patient to unnecessary risk, unqualified
capsulotomies worsen this burden to the developed and
developing world [8].
PCO is an extremely common development in patients
after cataract extraction and in many mild cases it may not
be immediately obvious whether it is visually significant.
Patients may have reduced vision from other undeter-
mined causes or have some measures of visual function
that are not reduced at all.
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Information is needed that will help the practitioners to
decide on the visual significance of a patient's PCO using
tools that are easily available.
The specific aim of this study was to assess the correlation
between preoperative measures that are easily performed
(fundus visibility, capsule opacity grading and initial glare
testing) with eventual visual function improvements after
Nd: YAG capsulotomy. This information would be of use
to practitioners when deciding whether a patient had PCO
that was clinically significant. In other words, we aimed to
test the clinical utility of these preoperative tests for
Nd:YAG laser capsulotomy.
Methods
Local research ethical committee approval for the study
was obtained and the study was performed in accordance
with the treaty of Helsinki. 26 consecutive patients who
had been referred for Nd: YAG capsulotomies for poste-
rior capsular opacification were recruited and full
informed consent was obtained. Patients excluded were
those that had media opacities other than PCO or were
not suitable for capsulotomy treatment. Patients in whom
macular or disc pathologies were present were excluded
from posterior pole assessment arm of the study as grad-
ing of visualisation would not be valid. Patients were
roughly equally divided between silicone and acrylic
IOLs.
Prior to Nd:YAG capsulotomy, the patients visual func-
tion was assessed with their normal physiological pupil
state in terms of best corrected distance and near visual
acuity using Bailey Lovie logMAR charts and contrast sen-
sitivity with and without glare, using a Pelli-Robson chart
under standard illumination levels at 1 meter. Glare was
tested using a Mentor brightness acuity tester (BAT)
instrument (set at medium illumination levels) and
recorded as the level of contrast sensitivity chart read
when exposed to the BAT.
Pupils were dilated with topical 1% tropicamide. After a
minimum of 20 minutes, the size of the pupil was
recorded using a millimetre ruler and the PCO was graded
according to the slit-lamp appearance (grade 0 to 4). Use
of such slit lamp grading has been established in scientific
literature for PCO assessment [9-16] There are of course
many other systems available for assessment of PCO [17]
We chose a system based on slit lamp grading as it is the
most commonly performed method of PCO assessment
in practice. Many such slit lamp grading systems exist, but
none have been proven to be gold standard in terms of
clinical utility. After our own studies on the effect of PCO
on visual function [18], we decided to use a protocol
based on that described by Sellman and Lindstrom [19],
recording pearls and fibrosis separately, which we feel is
likely to be as clinically valid as any system that is com-
monly used in pre-assessment for Nd;YAG capsulotomy.
All these tests were performed by one practitioner (T.A.),
who was masked to fundus gradings, using the following
scale, for pearls and fibrosis separately;
0 None visible at all
1 Visible but none reaching to IOL edge
2 At IOL edge
3 Well Inside IOL edge but visual axis clear
4 Across visual axis
Visualisation of the posterior pole was then assessed by
examining the optic disc and macula using a Volk 90D
lens. Visualisation of the optic disc was subjectively
graded according to the following scale (adapted from the
Madurai Intraocular lens study IV [20]):
0 Clear view of optic disc margin, blood vessels at the
optic disc and nerve fibre layer (NFL examined using the
red-free filter)
1 Clear view of optic disc margin, but disc blood vessels
and/or nerve fibre layer are not clearly seen
2 Optic disc margin, as well as disc blood vessels and
nerve fibre layer are not clearly seen
Visualisation of the macula was subjectively graded
according to the following scale:
0 Clear view of foveal reflex, peri-foveal blood vessels and
nerve fibre layer
1 Diminished foveal reflex, but clear view of peri-foveal
blood vessels and nerve fibre layer
2 Blurred foveal reflex, peri-foveal blood vessels and/or
nerve fibre layer
The totals for the visualisations of the optic disc and the
macula were combined to produce a total posterior pole
visualisation score (PolVS), ranging from 0 to 4 in order
of decreasing visualisation.
All examinations of the posterior pole were carried out by
the same examiner (NP). In order to be masked as to
whether the patient was pre- or post- Nd:YAG capsulot-
omy, NP examined the fundus with the lenses already
placed in front of the eye, thus obscuring any anterior seg-
ment view.BMC Ophthalmology 2004, 4:13 http://www.biomedcentral.com/1471-2415/4/13
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The patients then had Nd:YAG capsulotomy by the same
surgeon (TA). This involved initial setting of 1 mJ and
subsequent rises of 0.5 mJ as necessary to pierce the pos-
terior capsule. The laser treatment was initiated off axis in
a horizontal line across centre, followed by a line in the
vertical axis to form a cross. Any obvious lines of capsule
tear were treated with laser if deemed beneficial and over-
all energy used was kept to a minimum. Treatments in this
manner produced small capsulotomies of size 2–3 mm
diameter. Size of capsulotomy was dictated by ease of
making openings, and concerns over energy used. In gen-
eral the aim was to create an opening using minimum
energy, which might be small, but which could be
enlarged at follow up visits if deemed necessary.
Four weeks post Nd: YAG capsulotomy, the patients were
reassessed again in terms of visual function as described
earlier, by the same practitioner (TA). The pupils were
dilated using 1% tropicamide and after a minimum 20-
minute interval, the size of the pupil was recorded. The
PolVS was again graded according to the same scales as
before, by the same examiner (NP), again masked as to
the state of the posterior capsule. Four weeks post-cap-
sulotomy was chosen for re-examination, on the basis of
evidence suggesting that capsulotomies enlarged progres-
sively up to one month after Nd: YAG laser and then sta-
bilised thereafter [21]
On inspection, the data was found to be of skewed distri-
bution. All correlation calculations were therefore per-
formed using the Spearman's rank correlation
coefficients. Means were compared using Wilcoxon signed
ranks test for non-normally distributed data. Significance
was at the p < 0.05 level. Because the visualisation scale
was composed of a combination of sub-scales (2 items for
PolVS), internal validity was determined by the Cronbach
test of reliability19,20. This is a commonly used test sta-
tistic to determine the degree with which constituent
items within a scale correlate with each other. An alpha
coefficient of = 0.7 is considered necessary for a composite
of measurements to be considered a scale. Statistical anal-
ysis was performed using SPSS for Windows (version 8.0)
for all calculations.
Results
A total of 26 eyes of 26 patients were recruited into the
study. Mean age was 75.2 years (range 52 to 90). There
were 14 females and 12 males. 2 patients only had one
examination pre-Nd:YAG capsulotomy, and declined any
further examinations. Therefore, 24 patients were seen
pre- and post- Nd:YAG capsulotomy. The PolVS scale was
found to be internally reliable and consistent (α coeffi-
cient = 0.7824). Mean "pearl" grading score was 3.3 (±
1.3) and mean "fibrosis" grading score was 2.3 (± 1.4).
5 patients were omitted from PolVS score as macular or
disc pathology prevented objective grading. Mean
improvement of PolVS (n = 19) was 1.95 (S.D. ± 1.31)
(95% C.I. 1.32 to 2.58) (p < 0.0001, Wilcoxon signed
ranks test).
Improvements in the PolVS score after Nd: YAG capsulot-
omies are shown in fig. 1.
Mean improvement of distance logMAR visual acuity was
0.32 (± 0.29) (95% CI 0.20 to 0.44) and near logMAR vis-
ual acuity was 0.32 (± 0.29) (95% CI 0.20 to 0.44). Mean
improvement of log contrast sensitivity was -0.41 (± 0.39)
(95% CI 0.25 to 0.57) and glare testing vision was -0.35
(S.D. ± 0.41) (95% CI 0.18 to 0.52). (Improved contrast
sensitivity and glare testing visual function are associated
with lower grading scores.) For all the above analyses, p <
0.0001, except for mean improvement in glare testing (p
= 0.001) (Wilcoxon signed ranks test).
The main aim of the study was to determine which pre-
operative assessments on patients attending for Nd: YAG
capsulotomy would correlate with eventual visual func-
tion outcome of the patient, and thus be useful clinical
measures. The results of the various correlation coefficient
analyses are shown in table 1. The table demonstrates that
a patient's improvement in visual function after laser cap-
sulotomy is correlated to measurements made before
treatment of pearls at slit lamp and posterior pole visibil-
ity score.
Boxplots of PolVS pre- and post-Nd:YAG capsulotomy Figure 1
Boxplots of PolVS pre- and post-Nd:YAG capsulotomy.
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Measurements of fibrosis at slit lamp and of glare do not
correlate with eventual improvements in vision after
capsulotomy.
Discussion
If it is decided to offer a patient Nd; YAG capsulotomy
treatment they need to be told of the likely benefits of the
treatment as well as risks. Information on potential visual
function improvements for each specific patient would be
especially welcome in decisions in uncertain cases and
higher risk patients such as high myopes.
Practitioners should have some evidence for the potential
benefit to visual function before suggesting treatment.
Retroilluminated photograph analysis by computer have
been correlated with improvements in vision [22] but
these tools are not available to most ophthalmologists in
the examination room. Practitioners are able to subjec-
tively estimate the amount of PCO on slit lamp examina-
tion of posterior capsule but often with more subtle PCO
it is difficult to assess clinical relevance. It is thought by
some [23] that contrast sensitivity with glare testing are
likely to be particularly sensitive to visual loss from PCO,
but of course these visual parameters are also open to
influence from many other ocular states. Visibility of discs
has been used as an assessment of the amount of PCO
[20] but without convincing evidence of validity.
Although all of the above tests have been used to try to
assess how much benefit a particular patient may gain
from capsulotomy, there has previously been little empir-
ical evidence supporting their use. This study provides
some evidence for the use and avoidance of various pre-
operative tests in assessing potential benefit from Nd;
YAG laser capsulotomy.
Preoperative glare measures
There has been some controversy as to the relative useful-
ness of the different measures of visual function for assess-
ing PCO severity [23-27], with some suggestion that glare
assessment might be particularly useful for such anterior
segment disorders [23,27] This study suggests that initial
glare measures with the BAT did not correlate with even-
tual improvements in any visual function. Our results do,
however, show a definite improvement in glare following
Nd:YAG capsulotomy, all of whom underwent a small
capsulotomy (2–3 mm). It appears that glare assessment
with BAT is of no clinical utility when assessing the poten-
tial improvement a patient may gain from Nd:YAG cap-
sulotomy. This may reflect the difficulties of BAT glare
measurement which has been found to be inconsistent in
some studies [28]. Indeed, glare assessment by any means
is not simple to perform reliably and with clinical utility.
Slit lamp assessment of PCO by practitioner
There were two types of PCO assessed, pearls and fibrosis,
both graded 0–4 with identical criteria for severity. The
study shows very clearly that the fibrosis score was not sig-
nificantly correlated to any improvements in visual func-
tion. The pearl score however was significant in
correlating with the eventual improvement of all visual
functions. This agrees with previous work using compu-
terised analysis of retro-illumination photographs, which
showed that only very central fibrosis affected vision
whereas pearls could be detrimental even in para-axial
locations [18] Other studies have also shown that pearls
have a greater effect on vision than fibrosis [29].
The assessment of fibrosis at slit lamp is commonly per-
formed before Nd:YAG capsulotomy, but according to
this study does not correlate with eventual visual out-
comes. This finding was perhaps the most poignant due to
the common clinical use of amount of fibrosis at slit lamp
when deciding whether a patient would benefit from
Table 1: Correlation cross-tabulation table between improvements in visual function and pre-treatment measures of glare, slit-lamp 
pearls, slit-lamp fibrosis and posterior pole visibility score (Polvs).
Improvement in Distance Visual Acuity Improvement in Contrast Sensitivity
Pre-Nd:YAG R = -0.30 R = -0.35
Glare Testing p = 0.159* p = 0.093*
Slit-lamp R = 0.67 R = 0.64
Pearls p < 0.0001 p = 0.001
Slit-lamp R = -0.01 R = 0.06
Fibrosis p = 0.950* p = 0.775*
Pre-Nd:YAG R = 0.56 R = 0.50
PolVS p = 0.012 p = 0.029
R = Spearman's Rank Correlation Coefficient
* = Not statistically significantBMC Ophthalmology 2004, 4:13 http://www.biomedcentral.com/1471-2415/4/13
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capsulotomy. The finding deserves further investigation,
but it may be that antero-posterior thickness of the fibro-
sis as well as density of opacification are important con-
tributory variables to any visual loss. This thickness of
PCO would not be easily assessed accurately and routinely
at slit lamp, and was not incorporated into the grading
scale used for this experiment.
In contrast, clinical utility of pearl assessment is demon-
strated, by its correlation with eventual improvement of
visual function.
Visualisation of posterior pole
Visualisation of posterior pole according to the scale
above correlated with improvements in visual acuity and
contrast sensitivity. Using the specific criteria as described
may have increased the objectivity of the test. This con-
firms expected agreement between the difficulty of visual-
ization of the posterior pole and the patient's own vision
of the outside world.
An assessment of the posterior pole along the suggested
guidelines is shown to have significant clinical utility.
It may be that some of the correlations found were due to
some criteria measured being closely related, for example,
pearls at sit lamp and visualisation of fundus. The num-
bers in this analysis were unfortunately insufficient for
stepwise multiple linear regression analysis, which could
be used in future studies to determine the relative impor-
tance of the different measures. However the principle
aims of the current study were realised with the presented
experimental protocol and statistical analysis.
Conclusions
This study confirms the clinical value of pre-YAG meas-
urements of pearls graded at slit lamp and posterior pole
visualisation.
However, other measures were not significantly correlated
with improvements in visual function, namely pre-YAG
testing of glare with BAT and pre-YAG grading of fibrosis
seen at slit lamp.
If a practitioner is uncertain as to the potential visual ben-
efit of an Nd:YAG capsulotomy, an assessment of poste-
rior pole visualisation or pearls at slit lamp should be
useful. There is little clinical utility shown from this study
in attempting glare assessment or assessment of fibrosis at
slit lamp and these assessments may lead to erroneous
expectations from treatment.
This information is of practical value to practitioners faced
with the common problem of assessing suitability of
patients for Nd: YAG capsulotomy. It should especially be
of use in more uncertain or high-risk cases to determine
whether referral to PCO treatment by Nd: YAG capsulot-
omy is clinically appropriate.
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